Tag Archives: Andrew Fein

Aimmune Therapeutics (AIMT) Receives a Hold from H.C. Wainwright

H.C. Wainwright analyst Andrew Fein reiterated a Hold rating on Aimmune Therapeutics (AIMT – Research Report) today and set a price target of $15.00. The company’s shares closed last Tuesday at $16.86. According to TipRanks.com, Fein is a 5-star analyst

Denali Therapeutics (DNLI) Received its Third Buy in a Row

After Morgan Stanley and Wedbush gave Denali Therapeutics (NASDAQ: DNLI) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Andrew Fein maintained a Buy rating on Denali Therapeutics today and set a price

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Syros Pharmaceuticals (NASDAQ: SYRS), Flexion Therapeutics (NASDAQ: FLXN) and Pacira Pharmaceuticals (NASDAQ: PCRX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Syros Pharmaceuticals (SYRS – Research Report), Flexion Therapeutics (FLXN – Research Report) and Pacira Pharmaceuticals (PCRX – Research Report). Syros Pharmaceuticals (SYRS) H.C.

H.C. Wainwright Reiterates a Buy Rating on Blueprint Medicines (BPMC)

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $66.00. The company’s shares closed last Wednesday at $58.97. According to TipRanks.com, Fein is a 5-star analyst

Constellation Pharmaceuticals (CNST) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Constellation Pharmaceuticals (CNST – Research Report) today and set a price target of $75.00. The company’s shares closed last Wednesday at $44.90. According to TipRanks.com, Fein is a 5-star analyst

Neurocrine (NBIX) Receives a Buy from H.C. Wainwright

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Neurocrine (NBIX – Research Report), with a price target of $125.00. The company’s shares closed last Wednesday at $103.48. According to TipRanks.com, Fein is a